{"pmid":32327306,"title":"New paths for sustainable solutions to tackle global and emerging infectious threats.","text":["New paths for sustainable solutions to tackle global and emerging infectious threats.","With the dramatic background of a newly emerged virus (SARS-CoV-2) spreading around the world, Coronavirus and other infectious health threats for the human and animal populations were illustrated and debated in excellent presentations at the IABS meeting 26-28 of February 2020. Historical evidence of pandemics and lessons learned from recent epidemics or epizootics caused by many pathogens (e.g., Ebola, Zika, and African Swine Fever viruses) illustrated the overarching need for close international cooperation. New and old technologies in vaccine development and their use were presented, resulting in a call for greater interaction between the human and the veterinary fields in order to leverage the expertise and knowledge in both human and animal medicine. The One Health concept was also emphasized for eliminating the 59,000 fatal human rabies cases annually attributed to unvaccinated dogs. For preventable, infectious diseases commonly spreading in the poorer regions of the world, a new regulatory approach and governance structure was called for to give access to affordable vaccines. Vaccines were touted as one of the most successful health invention ever introduced; on a similar level to health improvements due to clean water.","Biologicals","Holm, Anja","32327306"],"abstract":["With the dramatic background of a newly emerged virus (SARS-CoV-2) spreading around the world, Coronavirus and other infectious health threats for the human and animal populations were illustrated and debated in excellent presentations at the IABS meeting 26-28 of February 2020. Historical evidence of pandemics and lessons learned from recent epidemics or epizootics caused by many pathogens (e.g., Ebola, Zika, and African Swine Fever viruses) illustrated the overarching need for close international cooperation. New and old technologies in vaccine development and their use were presented, resulting in a call for greater interaction between the human and the veterinary fields in order to leverage the expertise and knowledge in both human and animal medicine. The One Health concept was also emphasized for eliminating the 59,000 fatal human rabies cases annually attributed to unvaccinated dogs. For preventable, infectious diseases commonly spreading in the poorer regions of the world, a new regulatory approach and governance structure was called for to give access to affordable vaccines. Vaccines were touted as one of the most successful health invention ever introduced; on a similar level to health improvements due to clean water."],"journal":"Biologicals","authors":["Holm, Anja"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327306","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.biologicals.2020.04.003","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Ebola","Zika"],"e_drugs":["Water"],"_version_":1664996914994610176,"score":8.518259,"similar":[{"pmid":32315124,"title":"Is COVID-19 the first pandemic that evolves into a panzootic?","text":["Is COVID-19 the first pandemic that evolves into a panzootic?","SARS-CoV-2 is a zoonotic virus that has achieved community spread among humans and become a pandemic. Transmission from humans to dogs, domestic cats, tigers, and lions has occurred. Pigs, cats, ferrets, and primates have been identified as good candidates for susceptibility to SARS-CoV-2. The potential implications indicate the need for One Health surveillance, intervention, and management strategies to mitigate the effects on animal populations and prevent a second preparedness failure during this health emergency.","Vet Ital","Gollakner, Rania","Capua, Ilaria","32315124"],"abstract":["SARS-CoV-2 is a zoonotic virus that has achieved community spread among humans and become a pandemic. Transmission from humans to dogs, domestic cats, tigers, and lions has occurred. Pigs, cats, ferrets, and primates have been identified as good candidates for susceptibility to SARS-CoV-2. The potential implications indicate the need for One Health surveillance, intervention, and management strategies to mitigate the effects on animal populations and prevent a second preparedness failure during this health emergency."],"journal":"Vet Ital","authors":["Gollakner, Rania","Capua, Ilaria"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315124","week":"202017|Apr 20 - Apr 26","doi":"10.12834/VetIt.2246.12523.1","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520090640385,"score":159.81822},{"pmid":32279686,"pmcid":"PMC7167298","title":"Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us.","text":["Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us.","For a large number of health care providers world-wide, the coronavirus disease 2019 (COVID-19) pandemic is their first experience in population-based care. In past decades, lower population densities, infectious disease outbreaks, epidemics, and pandemics were rare and driven almost exclusively by natural disasters, predatory animals, and war. In the early 1900s, Sir William Osler first advanced the knowledge of zoonotic diseases that are spread from reservoir animals to human animals. Once rare, they now make up 71% or more of new diseases. Globally, zoonotic spread occurs for many reasons. Because the human population has grown in numbers and density, the spread of these diseases accelerated though rapid unsustainable urbanization, biodiversity loss, and climate change. Furthermore, they are exacerbated by an increasing number of vulnerable populations suffering from chronic deficiencies in food, water, and energy. The World Health Organization (WHO) and its International Health Regulation (IHR) Treaty, organized to manage population-based diseases such as Influenza, severe acute respiratory syndrome (SARS), H1N1, Middle East respiratory syndrome (MERS), HIV, and Ebola, have failed to meet population-based expectations. In part, this is due to influence from powerful political donors, which has become most evident in the current COVID-19 pandemic. The global community can no longer tolerate an ineffectual and passive international response system, nor tolerate the self-serving political interference that authoritarian regimes and others have exercised over the WHO. In a highly integrated globalized world, both the WHO with its IHR Treaty have the potential to become one of the most effective mechanisms for crisis response and risk reduction world-wide. Practitioners and health decision-makers must break their silence and advocate for a stronger treaty, a return of the WHO's singular global authority, and support highly coordinated population-based management. As Osler recognized, his concept of \"one medicine, one health\" defines what global public health is today.","Prehosp Disaster Med","Burkle, Frederick M","32279686"],"abstract":["For a large number of health care providers world-wide, the coronavirus disease 2019 (COVID-19) pandemic is their first experience in population-based care. In past decades, lower population densities, infectious disease outbreaks, epidemics, and pandemics were rare and driven almost exclusively by natural disasters, predatory animals, and war. In the early 1900s, Sir William Osler first advanced the knowledge of zoonotic diseases that are spread from reservoir animals to human animals. Once rare, they now make up 71% or more of new diseases. Globally, zoonotic spread occurs for many reasons. Because the human population has grown in numbers and density, the spread of these diseases accelerated though rapid unsustainable urbanization, biodiversity loss, and climate change. Furthermore, they are exacerbated by an increasing number of vulnerable populations suffering from chronic deficiencies in food, water, and energy. The World Health Organization (WHO) and its International Health Regulation (IHR) Treaty, organized to manage population-based diseases such as Influenza, severe acute respiratory syndrome (SARS), H1N1, Middle East respiratory syndrome (MERS), HIV, and Ebola, have failed to meet population-based expectations. In part, this is due to influence from powerful political donors, which has become most evident in the current COVID-19 pandemic. The global community can no longer tolerate an ineffectual and passive international response system, nor tolerate the self-serving political interference that authoritarian regimes and others have exercised over the WHO. In a highly integrated globalized world, both the WHO with its IHR Treaty have the potential to become one of the most effective mechanisms for crisis response and risk reduction world-wide. Practitioners and health decision-makers must break their silence and advocate for a stronger treaty, a return of the WHO's singular global authority, and support highly coordinated population-based management. As Osler recognized, his concept of \"one medicine, one health\" defines what global public health is today."],"journal":"Prehosp Disaster Med","authors":["Burkle, Frederick M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32279686","week":"202016|Apr 13 - Apr 19","doi":"10.1017/S1049023X20000515","keywords":["sir william osler","world health organization","coronavirus","global public health","globalization","pandemics"],"source":"PubMed","weight":0,"e_drugs":["Water"],"_version_":1664636704070303745,"score":150.29549},{"pmid":32269068,"pmcid":"PMC7164390","title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","text":["Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control.","Science","Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao","32269068"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control."],"journal":"Science","authors":["Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269068","week":"202015|Apr 06 - Apr 12","doi":"10.1126/science.abb7015","source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637315567321088,"score":147.7285},{"pmid":32325980,"title":"Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.","text":["Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.","Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellow fever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among many other viruses have been reported from different African countries. The paucity of information, lack of knowledge, limited resources, and climate change, coupled with cultural traditions make the African continent a hotspot for vector-borne and zoonotic viral diseases, which may spread globally. Currently, there is no information available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa. The findings will help us understand the trend of emerging and re-emerging virus diseases within the African continent. The findings recommend active surveillance of viral diseases and strict implementation of One Health measures in Africa to improve human public health and reduce the possibility of potential pandemics due to zoonotic viruses.","Pathogens","Chauhan, Ravendra P","Dessie, Zelalem G","Noreddin, Ayman","El Zowalaty, Mohamed E","32325980"],"abstract":["Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellow fever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among many other viruses have been reported from different African countries. The paucity of information, lack of knowledge, limited resources, and climate change, coupled with cultural traditions make the African continent a hotspot for vector-borne and zoonotic viral diseases, which may spread globally. Currently, there is no information available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa. The findings will help us understand the trend of emerging and re-emerging virus diseases within the African continent. The findings recommend active surveillance of viral diseases and strict implementation of One Health measures in Africa to improve human public health and reduce the possibility of potential pandemics due to zoonotic viruses."],"journal":"Pathogens","authors":["Chauhan, Ravendra P","Dessie, Zelalem G","Noreddin, Ayman","El Zowalaty, Mohamed E"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32325980","week":"202017|Apr 20 - Apr 26","doi":"10.3390/pathogens9040301","keywords":["africa","covid-19","ebola","rift valley fever virus","sars-cov-2","west nile virus","avian influenza","coronaviruses","dengue","emerging","epidemiology","hemorrhagic fever","infectious diseases","influenza a virus","monkeypox","one health","pandemic","rabies","re-emerging","simian immunodeficiency","vector-borne","virus","zoonosis"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","chikungunya","dengue"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664996914885558272,"score":147.674},{"pmid":32265848,"pmcid":"PMC7105881","title":"Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.","text":["Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.","Seven coronaviruses (CoVs) have been isolated from humans so far. Among them, three emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and a newly identified CoV (2019-nCoV), once caused or continue to cause severe infections in humans, posing significant threats to global public health. SARS-CoV infection in humans (with about 10% case fatality rate) was first reported from China in 2002, while MERS-CoV infection in humans (with about 34.4% case fatality rate) was first reported from Saudi Arabia in June 2012. 2019-nCoV was first reported from China in December 2019, and is currently infecting more than 70000 people (with about 2.7% case fatality rate). Both SARS-CoV and MERS-CoV are zoonotic viruses, using bats as their natural reservoirs, and then transmitting through intermediate hosts, leading to human infections. Nevertheless, the intermediate host for 2019-nCoV is still under investigation and the vaccines against this new CoV have not been available. Although a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potential factors affecting these subunit vaccines are also illustrated. Overall, this review will be helpful for rapid design and development of vaccines against the new 2019-nCoV and any future CoVs with pandemic potential. This review was written for the topic of Antivirals for Emerging Viruses: Vaccines and Therapeutics in the Virology section of Frontiers in Microbiology.","Front Microbiol","Wang, Ning","Shang, Jian","Jiang, Shibo","Du, Lanying","32265848"],"abstract":["Seven coronaviruses (CoVs) have been isolated from humans so far. Among them, three emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and a newly identified CoV (2019-nCoV), once caused or continue to cause severe infections in humans, posing significant threats to global public health. SARS-CoV infection in humans (with about 10% case fatality rate) was first reported from China in 2002, while MERS-CoV infection in humans (with about 34.4% case fatality rate) was first reported from Saudi Arabia in June 2012. 2019-nCoV was first reported from China in December 2019, and is currently infecting more than 70000 people (with about 2.7% case fatality rate). Both SARS-CoV and MERS-CoV are zoonotic viruses, using bats as their natural reservoirs, and then transmitting through intermediate hosts, leading to human infections. Nevertheless, the intermediate host for 2019-nCoV is still under investigation and the vaccines against this new CoV have not been available. Although a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potential factors affecting these subunit vaccines are also illustrated. Overall, this review will be helpful for rapid design and development of vaccines against the new 2019-nCoV and any future CoVs with pandemic potential. This review was written for the topic of Antivirals for Emerging Viruses: Vaccines and Therapeutics in the Virology section of Frontiers in Microbiology."],"journal":"Front Microbiol","authors":["Wang, Ning","Shang, Jian","Jiang, Shibo","Du, Lanying"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265848","week":"202015|Apr 06 - Apr 12","doi":"10.3389/fmicb.2020.00298","keywords":["2019-ncov","mers-cov","sars-cov","human coronaviruses","pathogenesis","subunit vaccines"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["China","Saudi Arabia","China","Frontiers","Microbiology"],"countries":["Saudi Arabia","China"],"countries_codes":["SAU|Saudi Arabia","CHN|China"],"_version_":1664637636041506816,"score":145.88774}]}